0001410939-23-000061.txt : 20230503
0001410939-23-000061.hdr.sgml : 20230503
20230503173137
ACCESSION NUMBER: 0001410939-23-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Westby Keith
CENTRAL INDEX KEY: 0001696429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 23885559
MAIL ADDRESS:
STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: (609) 474-6755
MAIL ADDRESS:
STREET 1: 8 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
wf-form4_168314947475000.xml
FORM 4
X0407
4
2023-05-01
0
0001410939
IVERIC bio, Inc.
ISEE
0001696429
Westby Keith
C/O IVERIC BIO, INC.
8 SYLVAN WAY
PARSIPPANY
NJ
07054
0
1
0
0
SVP, Chief Operating Officer
1
Common Stock
2023-05-01
4
M
0
8786
4.52
A
48438
D
Common Stock
2023-05-01
4
S
0
8786
37.12
D
39652
D
Common Stock
2023-05-01
4
M
0
11214
5.22
A
50866
D
Common Stock
2023-05-01
4
S
0
11214
37.12
D
39652
D
Common Stock
2023-05-02
4
M
0
20000
2.94
A
59652
D
Common Stock
2023-05-02
4
S
0
20000
37.81
D
39652
D
Stock Option (right to buy)
4.52
2023-05-01
4
M
0
8786
4.52
D
2027-01-29
Common Stock
8786.0
0
D
Stock Option (right to buy)
5.22
2023-05-01
4
M
0
11214
5.22
D
2029-12-08
Common Stock
11214.0
63786
D
Stock Option (right to buy)
2.94
2023-05-02
4
M
0
20000
2.94
D
2027-12-18
Common Stock
20000.0
120000
D
The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2022.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $36.79 to $37.50 per share on May 1, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $37.63 to $38.04 per share on May 2, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
This stock option award was granted on January 30, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
This stock option award was granted on December 9, 2019 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby
2023-05-03